Please try another search
July 26 (Reuters) - Loblaw Companies Ltd L.TO
* Loblaw - CEO, re: further reduction in generic drug pricing by Québec Government, "will put increased pressure on our pharmacy business model" - conf call
* Loblaw - in 2018, expect significant regulatory headwinds from both accelerating healthcare reform and increases in minimum wage - CEO on conf call
* Loblaw - "we need to increase our focus on cost reductions and accelerate our plans to realize efficiencies" - president on conf call
* Loblaw - in 2018, estimate impact on labor expenses from increases in minimum wage rates to be about $190 million - president on conf call Further company coverage: L.TO
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.